WorksheetsPHA 057 SAS #6 Summary of drugs
Total questions: 62
Worksheet time: 1hrs 2mins
Give 2 Rapid acting insulin:
(a)
Give short-acting insulin:
(a)
Give Intermediate acting Insulin:
(a)
Give 2 Long-acting insulin:
(a)
MOA of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec:
(a)
Drug classification of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec:
(a)
Clinical Applications of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec:
(a)
Adverse effects of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec (INSULINS):
(a)
Give 2 drugs classified as Sulfonylureas:
(a)
Drug classification of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide:
(a)
MOA of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide:
(a)
Clinical application of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide:
(a)
Adverse effects of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide (Sulfonylureas):
(a)
GIve 2 examples of Meglitinide Analogs; D-Phenylanaline Derivative
(a)
Drug classification of Repaglinide, Nateglinide, and Mitiglinide
(a)
MOA of Repaglinide, Nateglinide, and Mitiglinide:
(a)
Clinical Application of Repaglinide, Nateglinide, and Mitiglinide:
(a)
Adverse effect of Repaglinide, Nateglinide, and Mitiglinide
(a)
Give example of Biguanides
(a)
Drug classification of Metformin:
(a)
MOA of Metformin:
(a)
Clinical Application of Metformin:
(a)
Give 2 adverse effects of Metformin (Biguanides):
(a)
Give 2 example of Alpha-Glucosidase Inhibitors:
(a)
Drug classification of Voglibose, Acarbose,a nd Miglitol:
(a)
MOA of Voglibose, Acarbose,a nd Miglitol:
(a)
Clinical Application of Voglibose, Acarbose,a nd Miglitol:
(a)
Give 2 examples of Thiazolidinediones:
(a)
Drug classification of Pioglitazone and Rosiglitazone:
(a)
Clinical Application of Pioglitazone and Rosiglitazone:
(a)
Adverse effect of Pioglitazone and Rosiglitazone (Thiazolidinediones):
(a)
Give 2 example of Glucagon-like Polypeptide-1 (GLP-1) Receptor Agonists:
(a)
Drug classification of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide:
(a)
MOA of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide:
(a)
Clinical Application of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide:
(a)
Clinical Application of Liraglutide:
(a)
Adverse effect of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide (Glucagon-like Polypeptide-1 (GLP-1) Receptor Agonists):
(a)
Give 2 example of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors:
(a)
Drug classification of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin:
(a)
MOA of of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin:
(a)
Clinical Application of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin:
(a)
Adverse effect of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors):
(a)
Give 2 example of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors:
(a)
Drug classification of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin:
(a)
MOA of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin:
(a)
Clinical Application of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin:
(a)
Adverse effect of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin (Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors):
(a)
Give example of Islet Amyloid Polypepetide Analog:
(a)
MOA of Pramlintide
(a)
Drug classification of Pramlintide:
(a)
Clinical Application of Pramlintide:
(a)
Adverse effect Pramlintide (Islet Amyloid Polypepetide Analog);
(a)
Give example of Bile Acid Sequestrant:
(a)
Drug classification of Colesevelam hydrochloride:
(a)
MOA of Colesevelam hydrochloride:
(a)
Clinical Application of Colesevelam hydrochloride:
(a)
Adverse effect of Colesevelam hydrochloride:
(a)
Give example of Dopamine Agonist:
(a)
Drug classification of Bromocriptine:
(a)
MOA of Bromocriptine:
(a)
Clinical Application of Bromocriptine:
(a)
Adverse effect of Bromocriptine ( Dopamine Agonists):
(a)
